Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

News Daily News

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

L.A. McKeown

July 15, 2025

News Conference News CX Symposium 2025

Cost Surprises and Delayed Care in Women: BASIL-2 and BEST-CLI

L.A. McKeown

April 30, 2025

News Conference News VIVA 2024

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

L.A. McKeown

November 06, 2024

News Opinion CV Team Dispatch

July 2024 Dispatch for the CV Team

L.A. McKeown

July 01, 2024

News Daily News

BASIL-3: More Questions Than Answers About Drug-Coated Devices in CLTI

L.A. McKeown

April 24, 2024

News Conference News ACC 2024

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

Caitlin E. Cox

April 10, 2024

News Conference News CRT 2024

CLIPPER: Emphasis on Faster Revascularization Could Change CLTI Care

L.A. McKeown

March 20, 2024

News Opinion CV Team Dispatch

January 2024 Dispatch for the CV Team

L.A. McKeown

January 01, 2024

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Daily News

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

L.A. McKeown

July 11, 2023

News Conference News LINC 2023

Early Data on Temporary Spur in BTK PAD Show Efficacy, Limited Recoil

L.A. McKeown

June 09, 2023

News Conference News SCAI 2023

CLIPPER Attempts to Draw Out Useful Quality Metrics for CLTI

L.A. McKeown

May 25, 2023

News Daily News

PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI

L.A. McKeown

March 29, 2023

News Daily News

Only Half of Revascularized PAD Patients Receive GDMT

L.A. McKeown

February 14, 2023

News Opinion CV Team Dispatch

September 2022 News Roundup

L.A. McKeown

September 01, 2022

News Daily News

PAD Significantly Ups Morbidity and Mortality in AMICS

L.A. McKeown

March 29, 2022

News Opinion CV Team Dispatch

September 2021 News Roundup

L.A. McKeown

September 01, 2021

News Daily News

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

L.A. McKeown

August 10, 2021

News Daily News

Outcome Differences Between Men and Women With PAD: EUCLID Insights

L.A. McKeown

February 11, 2020

News Daily News

AHA Outlines Diagnosis, Treatment Options for Underrecognized Critical Limb Ischemia

Caitlin E. Cox

August 12, 2019

Advertisement

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

Cost Surprises and Delayed Care in Women: BASIL-2 and BEST-CLI

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

July 2024 Dispatch for the CV Team

BASIL-3: More Questions Than Answers About Drug-Coated Devices in CLTI

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

CLIPPER: Emphasis on Faster Revascularization Could Change CLTI Care

January 2024 Dispatch for the CV Team

October 2023 News Roundup

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

Early Data on Temporary Spur in BTK PAD Show Efficacy, Limited Recoil

CLIPPER Attempts to Draw Out Useful Quality Metrics for CLTI

PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI

Only Half of Revascularized PAD Patients Receive GDMT

September 2022 News Roundup

PAD Significantly Ups Morbidity and Mortality in AMICS

September 2021 News Roundup

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

Outcome Differences Between Men and Women With PAD: EUCLID Insights

AHA Outlines Diagnosis, Treatment Options for Underrecognized Critical Limb Ischemia

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content